Skip to main content
NCBI home page
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 1996 Jan;5(1):89–97. doi: 10.1002/pro.5560050111

A recombinant peptide model of the first nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator: comparison of wild-type and delta F508 mutant forms.

I Yike 1, J Ye 1, Y Zhang 1, P Manavalan 1, T A Gerken 1, D G Dearborn 1
PMCID: PMC2143253  PMID: 8771200

Abstract

A series of recombinant peptides, each including the sequence proposed to be the first nucleotide-binding fold of cystic fibrosis transmembrane conductance regulator (CFTR), has been produced in an attempt to find a model peptide that would autologously fold into a soluble structure with native-like properties. The peptide NBDIF, which contains the 267-amino acid sequence of CFTR from 384 to 650, meets these requirements. The peptide was produced with a high expression bacterial plasmid pRSET, purified from inclusion bodies following solubilization with 6 M guanidine-HCl and refolded from 8 M urea. Competitive displacement of trinitrophenol-ATP by nucleotides reveals binding of ATP and related nucleotides with KDs in the low micromolar range; the KD for ATP gamma S is 1.0 +/- 0.4 microM and for ADP 8.8 +/- 3.1 microM. The native-like character of the model peptide's structure is further supported by the findings that the KD for the ATP analog, 5'-adenylimidodiphosphate, is fourfold lower than the KD for the methylene analog, 5'-adenylmethylenediphosphonate, and that ATP binding slows the trypsin proteolysis of NBDIF. The CD spectra of NBDIF and the parallel peptide containing the most common cystic fibrosis mutation, deletion of Phe 508, are essentially indistinguishable, both spectra indicating 28% alpha-helix and 23% beta-sheet, with insignificant differences in the amounts of beta-turns and random structure. Extensive investigation using multiple conditions with highly purified preparations of the model peptides demonstrates that they do not support ATP hydrolysis. These large recombinant peptides offer practical models for the investigation of the first nucleotide-binding domain of CFTR.

Full Text

The Full Text of this article is available as a PDF (2.9 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ames G. F., Lecar H. ATP-dependent bacterial transporters and cystic fibrosis: analogy between channels and transporters. FASEB J. 1992 Jun;6(9):2660–2666. doi: 10.1096/fasebj.6.9.1377140. [DOI] [PubMed] [Google Scholar]
  2. Anderson M. P., Welsh M. J. Regulation by ATP and ADP of CFTR chloride channels that contain mutant nucleotide-binding domains. Science. 1992 Sep 18;257(5077):1701–1704. doi: 10.1126/science.1382316. [DOI] [PubMed] [Google Scholar]
  3. Cheng S. H., Gregory R. J., Marshall J., Paul S., Souza D. W., White G. A., O'Riordan C. R., Smith A. E. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell. 1990 Nov 16;63(4):827–834. doi: 10.1016/0092-8674(90)90148-8. [DOI] [PubMed] [Google Scholar]
  4. Chou P. Y., Fasman G. D. Prediction of the secondary structure of proteins from their amino acid sequence. Adv Enzymol Relat Areas Mol Biol. 1978;47:45–148. doi: 10.1002/9780470122921.ch2. [DOI] [PubMed] [Google Scholar]
  5. Fung B. K., Nash C. R. Characterization of transducin from bovine retinal rod outer segments. II. Evidence for distinct binding sites and conformational changes revealed by limited proteolysis with trypsin. J Biol Chem. 1983 Sep 10;258(17):10503–10510. [PubMed] [Google Scholar]
  6. Garnier J., Osguthorpe D. J., Robson B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol. 1978 Mar 25;120(1):97–120. doi: 10.1016/0022-2836(78)90297-8. [DOI] [PubMed] [Google Scholar]
  7. Gill S. C., von Hippel P. H. Calculation of protein extinction coefficients from amino acid sequence data. Anal Biochem. 1989 Nov 1;182(2):319–326. doi: 10.1016/0003-2697(89)90602-7. [DOI] [PubMed] [Google Scholar]
  8. Gregory R. J., Cheng S. H., Rich D. P., Marshall J., Paul S., Hehir K., Ostedgaard L., Klinger K. W., Welsh M. J., Smith A. E. Expression and characterization of the cystic fibrosis transmembrane conductance regulator. Nature. 1990 Sep 27;347(6291):382–386. doi: 10.1038/347382a0. [DOI] [PubMed] [Google Scholar]
  9. Gunderson K. L., Kopito R. R. Effects of pyrophosphate and nucleotide analogs suggest a role for ATP hydrolysis in cystic fibrosis transmembrane regulator channel gating. J Biol Chem. 1994 Jul 29;269(30):19349–19353. [PubMed] [Google Scholar]
  10. Hartman J., Huang Z., Rado T. A., Peng S., Jilling T., Muccio D. D., Sorscher E. J. Recombinant synthesis, purification, and nucleotide binding characteristics of the first nucleotide binding domain of the cystic fibrosis gene product. J Biol Chem. 1992 Apr 5;267(10):6455–6458. [PubMed] [Google Scholar]
  11. Hennessey J. P., Jr, Johnson W. C., Jr Information content in the circular dichroism of proteins. Biochemistry. 1981 Mar 3;20(5):1085–1094. doi: 10.1021/bi00508a007. [DOI] [PubMed] [Google Scholar]
  12. Higashijima T., Ferguson K. M., Smigel M. D., Gilman A. G. The effect of GTP and Mg2+ on the GTPase activity and the fluorescent properties of Go. J Biol Chem. 1987 Jan 15;262(2):757–761. [PubMed] [Google Scholar]
  13. Hwang T. C., Nagel G., Nairn A. C., Gadsby D. C. Regulation of the gating of cystic fibrosis transmembrane conductance regulator C1 channels by phosphorylation and ATP hydrolysis. Proc Natl Acad Sci U S A. 1994 May 24;91(11):4698–4702. doi: 10.1073/pnas.91.11.4698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hyde S. C., Emsley P., Hartshorn M. J., Mimmack M. M., Gileadi U., Pearce S. R., Gallagher M. P., Gill D. R., Hubbard R. E., Higgins C. F. Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature. 1990 Jul 26;346(6282):362–365. doi: 10.1038/346362a0. [DOI] [PubMed] [Google Scholar]
  15. John J., Sohmen R., Feuerstein J., Linke R., Wittinghofer A., Goody R. S. Kinetics of interaction of nucleotides with nucleotide-free H-ras p21. Biochemistry. 1990 Jun 26;29(25):6058–6065. doi: 10.1021/bi00477a025. [DOI] [PubMed] [Google Scholar]
  16. Kartner N., Augustinas O., Jensen T. J., Naismith A. L., Riordan J. R. Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland. Nat Genet. 1992 Aug;1(5):321–327. doi: 10.1038/ng0892-321. [DOI] [PubMed] [Google Scholar]
  17. Ko Y. H., Pedersen P. L. The first nucleotide binding fold of the cystic fibrosis transmembrane conductance regulator can function as an active ATPase. J Biol Chem. 1995 Sep 22;270(38):22093–22096. doi: 10.1074/jbc.270.38.22093. [DOI] [PubMed] [Google Scholar]
  18. Ko Y. H., Thomas P. J., Delannoy M. R., Pedersen P. L. The cystic fibrosis transmembrane conductance regulator. Overexpression, purification, and characterization of wild type and delta F508 mutant forms of the first nucleotide binding fold in fusion with the maltose-binding protein. J Biol Chem. 1993 Nov 15;268(32):24330–24338. [PubMed] [Google Scholar]
  19. Kyte J., Doolittle R. F. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982 May 5;157(1):105–132. doi: 10.1016/0022-2836(82)90515-0. [DOI] [PubMed] [Google Scholar]
  20. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  21. Larsen M., Willett R., Yount R. G. Imidodiphosphate and pyrophosphate: possible biological significance of similar structures. Science. 1969 Dec 19;166(3912):1510–1511. doi: 10.1126/science.166.3912.1510. [DOI] [PubMed] [Google Scholar]
  22. Li C., Ramjeesingh M., Reyes E., Jensen T., Chang X., Rommens J. M., Bear C. E. The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR. Nat Genet. 1993 Apr;3(4):311–316. doi: 10.1038/ng0493-311. [DOI] [PubMed] [Google Scholar]
  23. Logan J., Hiestand D., Daram P., Huang Z., Muccio D. D., Hartman J., Haley B., Cook W. J., Sorscher E. J. Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding. J Clin Invest. 1994 Jul;94(1):228–236. doi: 10.1172/JCI117311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Manavalan P., Dearborn D. G., McPherson J. M., Smith A. E. Sequence homologies between nucleotide binding regions of CFTR and G-proteins suggest structural and functional similarities. FEBS Lett. 1995 Jun 12;366(2-3):87–91. doi: 10.1016/0014-5793(95)00463-j. [DOI] [PubMed] [Google Scholar]
  25. Manavalan P., Johnson W. C., Jr Variable selection method improves the prediction of protein secondary structure from circular dichroism spectra. Anal Biochem. 1987 Nov 15;167(1):76–85. doi: 10.1016/0003-2697(87)90135-7. [DOI] [PubMed] [Google Scholar]
  26. Milburn M. V., Tong L., deVos A. M., Brünger A., Yamaizumi Z., Nishimura S., Kim S. H. Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. Science. 1990 Feb 23;247(4945):939–945. doi: 10.1126/science.2406906. [DOI] [PubMed] [Google Scholar]
  27. Mullen G. P., Shenbagamurthi P., Mildvan A. S. Substrate and DNA binding to a 50-residue peptide fragment of DNA polymerase I. Comparison with the enzyme. J Biol Chem. 1989 Nov 25;264(33):19637–19647. [PubMed] [Google Scholar]
  28. Quinton P. M., Reddy M. M. Control of CFTR chloride conductance by ATP levels through non-hydrolytic binding. Nature. 1992 Nov 5;360(6399):79–81. doi: 10.1038/360079a0. [DOI] [PubMed] [Google Scholar]
  29. Randak C., Roscher A. A., Hadorn H. B., Assfalg-Machleidt I., Auerswald E. A., Machleidt W. Expression and functional properties of the second predicted nucleotide binding fold of the cystic fibrosis transmembrane conductance regulator fused to glutathione-S-transferase. FEBS Lett. 1995 Apr 17;363(1-2):189–194. doi: 10.1016/0014-5793(95)00314-y. [DOI] [PubMed] [Google Scholar]
  30. Rich D. P., Gregory R. J., Cheng S. H., Smith A. E., Welsh M. J. Effect of deletion mutations on the function of CFTR chloride channels. Receptors Channels. 1993;1(3):221–232. [PubMed] [Google Scholar]
  31. Riordan J. R., Rommens J. M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J. L. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989 Sep 8;245(4922):1066–1073. doi: 10.1126/science.2475911. [DOI] [PubMed] [Google Scholar]
  32. Riordan J. R. The cystic fibrosis transmembrane conductance regulator. Annu Rev Physiol. 1993;55:609–630. doi: 10.1146/annurev.ph.55.030193.003141. [DOI] [PubMed] [Google Scholar]
  33. Thomas P. J., Pedersen P. L. Effects of the delta F508 mutation on the structure, function, and folding of the first nucleotide-binding domain of CFTR. J Bioenerg Biomembr. 1993 Feb;25(1):11–19. doi: 10.1007/BF00768063. [DOI] [PubMed] [Google Scholar]
  34. Travis S. M., Carson M. R., Ries D. R., Welsh M. J. Interaction of nucleotides with membrane-associated cystic fibrosis transmembrane conductance regulator. J Biol Chem. 1993 Jul 25;268(21):15336–15339. [PubMed] [Google Scholar]
  35. Tsui L. C. The spectrum of cystic fibrosis mutations. Trends Genet. 1992 Nov;8(11):392–398. doi: 10.1016/0168-9525(92)90301-j. [DOI] [PubMed] [Google Scholar]
  36. Venglarik C. J., Schultz B. D., Frizzell R. A., Bridges R. J. ATP alters current fluctuations of cystic fibrosis transmembrane conductance regulator: evidence for a three-state activation mechanism. J Gen Physiol. 1994 Jul;104(1):123–146. doi: 10.1085/jgp.104.1.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Walker J. E., Saraste M., Runswick M. J., Gay N. J. Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J. 1982;1(8):945–951. doi: 10.1002/j.1460-2075.1982.tb01276.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Welsh M. J., Smith A. E. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell. 1993 Jul 2;73(7):1251–1254. doi: 10.1016/0092-8674(93)90353-r. [DOI] [PubMed] [Google Scholar]
  39. Xia P., Culp L. A. Adhesion activity in fibronectin's alternatively spliced domain EDa (EIIIA) and its neighboring type III repeats: oncogene-dependent regulation. Exp Cell Res. 1994 Jul;213(1):253–265. doi: 10.1006/excr.1994.1197. [DOI] [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES